APA

Rubin D. T., Cohen R. D., Sandborn W. J., Lichtenstein G. R., Axler J., Riddell R. H., Zhu C., Barrett A. C., Bortey E. & Forbes W. P. (122017). Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. : Journal of Crohn's & colitis.

Chicago

Rubin David T, Cohen Russell D, Sandborn William J, Lichtenstein Gary R, Axler Jeffrey, Riddell Robert H, Zhu Cindy, Barrett Andrew C, Bortey Enoch and Forbes William P. 122017. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. : Journal of Crohn's & colitis.

Harvard

Rubin D. T., Cohen R. D., Sandborn W. J., Lichtenstein G. R., Axler J., Riddell R. H., Zhu C., Barrett A. C., Bortey E. and Forbes W. P. (122017). Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. : Journal of Crohn's & colitis.

MLA

Rubin David T, Cohen Russell D, Sandborn William J, Lichtenstein Gary R, Axler Jeffrey, Riddell Robert H, Zhu Cindy, Barrett Andrew C, Bortey Enoch and Forbes William P. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. : Journal of Crohn's & colitis. 122017.